CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Change in plasma volume and prognosis in acute decompensated heart failure: an observational cohort study Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5) Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes Diuretic Therapy for Patients With Heart Failure: JACC State-of-the-Art Review Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure

Clinical Trial2020 Mar;8(3):172-184.

JOURNAL:JACC Heart Fail. Article Link

Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone

JB Cohen, SJ Schrauben, JA Chirinos et al. Keywords: HFpEF; phenotypes; prognosis; disease management

Full Text PDF